The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Tumor necrosis factor α promoter polymorphisms and insulin resistance in nonalcoholic fatty liver disease
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity.
MATTEONI, C., YOUNOSSI, Z., GRAMLICH, T., BOPARAI, N., LIU, Y., & MCCULLOUGH, A. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70506-8 · Cited by 3,345
Hotamisligil, G. S., Peraldi, P., Budavari, A., Ellis, R., White, M. F., & Spiegelman, B. M. (1996) · Science · doi:10.1126/science.271.5249.665 · Cited by 2,630
Bonora, E., Targher, G., Alberiche, M., Bonadonna, R. C., Saggiani, F., Zenere, M. B., Monauni, T., & Muggeo, M. (2000) · Diabetes Care · doi:10.2337/diacare.23.1.57 · Cited by 2,456
Wilson, A. G., Symons, J. A., McDowell, T. L., McDevitt, H. O., & Duff, G. W. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.7.3195 · Cited by 2,218
Association of nonalcoholic fatty liver disease with insulin resistance
Marchesini, G., Brizi, M., Morselli-Labate, A. M., Bianchi, G., Bugianesi, E., McCullough, A. J., Forlani, G., & Melchionda, N. (1999) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)00271-5 · Cited by 1,568
Cytokines in Alcoholic and Nonalcoholic Steatohepatitis
Tilg, H., & Diehl, A. M. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011163432007 · Cited by 948
The natural history of nonalcoholic fatty liver: A follow-up study
Teli, M. R., James, O. F. W., Burt, A. D., Bennett, M. K., & Day, C. P. (1995) · Hepatology · doi:10.1002/hep.1840220616 · Cited by 925
Nonalcoholic Steatohepatitis: Definition and Pathology
Brunt, E. M. (2001) · Seminars in Liver Disease · doi:10.1055/s-2001-12925 · Cited by 911
Wilson, A. G., di Giovine, F. S., Blakemore, A. I. F., & Duff, G. W. (1992) · Human Molecular Genetics · doi:10.1093/hmg/1.5.353 · Cited by 881
The −308 tumor necrosis factor-α promoter polymorphism effects transcription
Kroeger, K. M., Carville, K. S., & Abraham, L. J. (1997) · Molecular Immunology · doi:10.1016/s0161-5890(97)00052-7 · Cited by 864
The homeostasis model in the San Antonio Heart Study.
Haffner, S. M., Miettinen, H., & Stern, M. P. (1997) · Diabetes Care · doi:10.2337/diacare.20.7.1087 · Cited by 788
Liver Pathology and the Metabolic Syndrome X in Severe Obesity
Marceau, P. (1999) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.5.1513 · Cited by 635
Prevalence of obesity and diabetes in patients with cryptogenic cirrhosis: A case-control study
Poonawala, A., Nair, S. P., & Thuluvath, P. J. (2000) · Hepatology · doi:10.1053/jhep.2000.17894 · Cited by 569
Sheth, S. G., Gordon, F. D., & Chopra, S. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-126-2-199701150-00008 · Cited by 513
Insulin resistance–associated hepatic iron overload
Mendler, M.-H., Turlin, B., Moirand, R., Jouanolle, A.-M., Sapey, T., Guyader, D., le Gall, J.-Y., Brissot, P., David, V., & Deugnier, Y. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70401-4 · Cited by 501
A polymorphic variation in a putative regulation box of the TNFA promoter region
D'Alfonso, S., & Richiardi, P. (1994) · Immunogenetics · doi:10.1007/bf00188619 · Cited by 350
Serum Ferritin as a Component of the Insulin Resistance Syndrome
Fernández-Real, J.-M., Ricart-Engel, W., Arroyo, E., Balançá, R., Casamitjana-Abella, R., Cabrero, D., Fernández-Castañer, M., & Soler, J. (1998) · Diabetes Care · doi:10.2337/diacare.21.1.62 · Cited by 328
Grove, J., Daly, A. K., Bassendine, M. F., & Day, C. P. (1997) · Hepatology · doi:10.1002/hep.510260119 · Cited by 287
Fernández-Real, J. M., Gutierrez, C., Ricart, W., Casamitjana, R., Fernández-Castañer, M., Vendrell, J., Richart, C., & Soler, J. (1997) · Diabetes · doi:10.2337/diab.46.9.1468 · Cited by 227
Fatty liveran additional and treatable feature of the insulin resistance syndrome
Knobler, H. (1999) · QJM · doi:10.1093/qjmed/92.2.73 · Cited by 198
Frequency and nature of cytokine gene polymorphisms in type 1 autoimmune hepatitis
Cookson, S., Constantini, P. K., Clare, M., Underhill, J. A., Bernal, W., Czaja, A. J., & Donaldson, P. T. (1999) · Hepatology · doi:10.1002/hep.510300412 · Cited by 180
Höhler, T., Kruger, A., Gerken, G., Schneider, P. M., zum Büschenfelde, K.-H. M., & Rittner, C. (1998) · Journal of Medical Virology · doi:10.1002/(sici)1096-9071(199803)54:3<173::aid-jmv5>3.0.co;2-2 · Cited by 158
Cytokine regulation of low density lipoprotein receptor gene transcription in HepG2 cells
Stopeck, A., NICHOLSON, A. C., Mancini, F. P., & Hajjar, D. P. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)85360-7 · Cited by 149
Zumsteg, U., Frigerio, S., & Holländer, G. A. (2000) · Diabetes · doi:10.2337/diabetes.49.1.39 · Cited by 109
Association of tumor necrosis factor polymorphism with primary sclerosing cholangitis
Bernal, W. E., Moloney, M. M., Underhill, J. A., et al. (1999) · Journal of Hepatology · doi:10.1016/s0168-8278(99)80068-3 · Cited by 103
Fargion, S. R., Valenti, L. V. C., Dongiovanni, P., Scaccabarozzi, A., Fracanzani, A. L., Taioli, E., Mattioli, M., Sampietro, M., & Fiorelli, G. (2001) · Blood · doi:10.1182/blood.v97.12.3707 · Cited by 87
Self-citationKwon, G., Xu, G. H., Marshall, C. A., & McDaniel, M. L. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.26.18702 · Cited by 81
Rasmussen, S. K., Urhammer, S. A., Jensen, J. N., Hansen, T. F., Borch‐Johnsen, K., & Pedersen, O. B. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.4.6563 · Cited by 81
Tumour necrosis factor-a promoter polymorphisms in primary biliary cirrhosis
Jones, D. E. J., Watt, F. E., Grove, J. I., Newton, J. L., Daly, A. K., Gregory, W. L., Day, C. P., James, O., & Bassendine, M. F. (1999) · Journal of Hepatology · doi:10.1016/s0168-8278(99)80067-1 · Cited by 67
Relationship between TNF‐α and iron metabolism in differentiating human monocytic THP‐1 cells
Scaccabarozzi, A., Arosio, P., Weiß, G., Valenti, L. V. C., Dongiovanni, P., Fracanzani, A. L., Mattioli, M., Levi, S., Fiorelli, G., & Fargion, S. (2000) · British Journal of Haematology · doi:10.1046/j.1365-2141.2000.02280.x · Cited by 62
Self-citationKoch, M., Kristian, R. E. T. T., Volk, A., Maerker, E., Haist, K., Weisser, M., Rettig, A., Renn, W., & Häring, H. (2000) · Diabetologia · doi:10.1007/s001250050027 · Cited by 43
Ito, H., Ohshima, A., Tsuzuki, M., Ohto, N., Takao, K., Hijii, C., Yanagawa, M., Ogasawara, M., & Nishioka, K. (2001) · Clinical and Experimental Pharmacology and Physiology · doi:10.1046/j.1440-1681.2001.03429.x · Cited by 43
Cited by
Nonalcoholic Steatohepatitis: Summary of An Aasld Single Topic Conference
Neuschwander-Tetri, B. A., & Caldwell, S. H. (2003) · Hepatology · doi:10.1053/jhep.2003.50193 · Cited by 2,154
Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis
Anstee, Q. M., Targher, G., & Day, C. P. (2013) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2013.41 · Cited by 1,747
Nonalcoholic fatty liver disease
Adams, L. A. (2005) · Canadian Medical Association Journal · doi:10.1503/cmaj.045232 · Cited by 1,610
Genetics and epigenetics of NAFLD and NASH: Clinical impact
Eslam, M., Valenti, L., & Romeo, S. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2017.09.003 · Cited by 971
Self-citationInsulin Resistance and Chronic Cardiovascular Inflammatory Syndrome
Fernández-Real, J. M., & Ricart, W. (2003) · Endocrine Reviews · doi:10.1210/er.2002-0010 · Cited by 886
Metadata
- Authors
- Valenti, L., Fracanzani, A. L., Dongiovanni, P., Santorelli, G., Branchi, A., Taioli, E., Fiorelli, G., & Fargion, S.
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2002-02
- Volume
- 122
- Issue
- 2
- Pages
- 274-280
- ISSN
- 0016-5085 (ISSN-L)
- OpenAlex
- W2167940070
- Cited by
- 289
- References
- 32
- FWCI
- 16.64
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.